VRTX

Vertex Pharmaceuticals Incorpor

Healthcare · in the S&P 500 and the Nasdaq-100

📍 Boston, United States · See it on the company map

The shape of the figures

Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.

Drag to turn the shape. Tap or point at a dot to read the figure behind it.

The figures and what each one means are below. A hollow dot means the company doesn't report that figure.

Figures from the annual reports are unavailable right now — please try again in a minute.

Key figures, against the S&P 500

Figures as of 9 Nov 2026, refreshed weekly

Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.

Valuation

P/E ratio?

35.1x

The share price is 35.1 times the last twelve months' earnings per share.

lowesthigher than 77% of the S&P 500highest

P/E on average earnings?

53.5x

The share price is 53.5 times earnings per share averaged over recent years.

lowesthigher than 84% of the S&P 500highest

Price / book

6.6x

The market values the company at 6.6 times the accounting value of its equity.

lowesthigher than 71% of the S&P 500highest

EV / EBIT?

29.8x

The company's value including its debt is 29.8 times its operating profit.

lowesthigher than 74% of the S&P 500highest

Free cash flow yield?

1.7%

Free cash flow equals 1.7% of the company's market value.

lowesthigher than 21% of the S&P 500highest

Profitability

Return on equity?

20.8%

Each 100 of shareholders' money produced 20.8 of net profit.

lowesthigher than 61% of the S&P 500highest

Return on assets?

10.6%

Each 100 of assets produced 10.6 of net profit.

lowesthigher than 77% of the S&P 500highest

Return on invested capital

21.2%

Each 100 invested by lenders and owners produced 21.2 of profit.

lowesthigher than 80% of the S&P 500highest

Operating margin?

38.8%

Of every 100 in sales, 38.8 was left as operating profit.

lowesthigher than 89% of the S&P 500highest

Debt

Debt / equity?

31.0%

Total debt equals 31% of shareholders' equity.

lowesthigher than 19% of the S&P 500highest

Net debt / EBITDA?

0.0x

Net debt equals 0 years of operating earnings (EBITDA).

lowesthigher than 16% of the S&P 500highest

Interest cover

350.1x

Operating profit was 350.1 times the interest bill.

lowesthigher than 97% of the S&P 500highest

Growth

Revenue growth

20.7%

Latest revenue is 20.7% above the average of earlier reported years.

lowesthigher than 72% of the S&P 500highest

Earnings growth

85.1%

Latest net profit is 85.1% above the average of earlier reported years.

lowesthigher than 89% of the S&P 500highest

⚠️ Not financial advice

This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.

This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.